By Josh Beckerman

Biora Therapeutics Inc. shares rose 26% to $6.83 on volume of more than 54.4 million shares, compared with a 65-day average of 940.298.

On Monday, after Biora discussed feedback from the Food and Drug Administration about its PGN-600 program, shares rose 2% to $2.11. The next day the stock skyrocketed to close at $5.40 after HC Wainwright raised its price target to $65 from $6.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

January 11, 2023 16:14 ET (21:14 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Biora Therapeutics (NASDAQ:BIOR)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more Biora Therapeutics Charts.
Biora Therapeutics (NASDAQ:BIOR)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Biora Therapeutics Charts.